Crescita Therapeutics Inc (CTX) — Capital Reinvestment Ratio
Crescita Therapeutics Inc (CTX) has a Capital Reinvestment Ratio of 1.74x as of December 2025, meaning it reinvests 2% of its operating cash flow (CA$416.00K) in capital expenditures (CA$724.00K). Check CTX tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Crescita Therapeutics Inc Capital Reinvestment Ratio (2019–2025)
This chart tracks Crescita Therapeutics Inc's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see Crescita Therapeutics Inc (CTX) cash flow conversion.
Annual Capital Reinvestment Ratio for Crescita Therapeutics Inc (2019–2025)
Year-by-year Capital Reinvestment Ratio for Crescita Therapeutics Inc from 2019 to 2025. See Crescita Therapeutics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.31x | CA$1.07 Million | CA$333.00K | ▼ -28.6% |
| 2024 | 0.43x | CA$2.73 Million | CA$1.19 Million | ▲ +578.8% |
| 2023 | 0.06x | CA$2.08 Million | CA$133.00K | ▲ +508.9% |
| 2020 | 0.01x | CA$5.61 Million | CA$59.00K | ▼ -74.0% |
| 2019 | 0.04x | CA$5.31 Million | CA$215.00K | — |